Caffeine Citrate: An Alternative to Theophylline for Apnea in Prematurity

Aranda JV Grondin D. Sasyniuk BI . Pharmacologic considerations in the therapy of neonatal apnea. Pediatr Clin North Am 1981; 28: 113–33.

Murat I. Moriette G. Blin MC. , The efficacy of caffeine in the treatment of recurrent idiopathic apnea in premature infants. J Pediatr 1981; 99: 984–9.

Cupit GC Serrano VA . Pediatric therapy. In: Katcher BS Young LY Koda-Kimble MA , eds. Applied therapeutics: The clinical use of drugs. San Francisco: Applied Therapeutics, Inc. 1983: 1469–72.

Lonnerholm G. Lindstrom B. Paalzow L. , Plasma theophylline and caffeine and plasma clearance of theophylline during theophylline treatment in the first year of life. Eur J Clin Pharmacol 1983; 24: 371–4.

Bory C. Baltassat P. Porthault M. , Metabolism of theophylline to caffeine in premature newborn infants. J Pediatr 1979; 94: 988–93.

Tserng K-Y Takieddine FN King KC . Developmental aspects of theophylline metabolism in premature infants. Clin Pharmacol Ther 1983; 33: 522–8.

Bada HS Khanna NN Somani SM. , Interconversion of theophylline and caffeine in newborn infants. J Pediatr 1979; 94: 993–5.

Aranda JV Cook CE Gorman W. , Pharmacokinetic profile of caffeine in the premature newborn infant with apnea. J Pediatr 1979; 94: 663–8.

Gorodischer R. Karplus M. Pharmacokinetic aspects of caffeine in premature infants with apnoea. Eur J Clin Pharmacol 1982; 22: 47–52.

Eisenberg MG Kang N. Stability in citrated caffeine solutions for injectable and enteral use. Am J Hosp Pharm 1984; 41: 2405–6.